• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Financial Services·MLAEM.PA
Share

Ashler et Manson SA Stocks

€ 2.62Last Updated 08.06.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

€ 118.10M

€ 2.62
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ashler Et Manson functions as a financial intermediary, specializing in the arrangement of loans for both real estate acquisitions and insurance-related purposes. The firm presents a diverse portfolio of financing solutions, offering loans with either fixed or fluctuating interest rates. These options cover various repayment methods, such as installment-based (amortizable) loans and those with a single lump-sum repayment at the end (in fine). Their services also extend to specialized financial instruments like bridge loans and traditional mortgage financing. Additionally, the company provides life insurance products. Ashler Et Manson was established in 2003 and operates from its primary location in Bordeaux, France.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.06.2026 11:24

Top story for the morning: SpaceX raised $75 billion, Musk one step away from first trillionaire status

12.06.2026 10:47

The dollar suffered its worst drop in a month after Trump's words on the closeness of peace with Iran

12.06.2026 09:00

Samsung is being probed for insider trading. Its stock is up 150% this year

12.06.2026 08:00

Forbright shares rose in early trading. It's the bank of Biden's former Democratic Party rival

12.06.2026 01:34

Rally ahead of SpaceX debut: best day since April for S&P 500 and Nasdaq, oil down 5%

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026